Evaxion Biotech's lung cancer candidate ready for clinic
![Evaxion Biotech CEO Lars Staal Wegner | Photo: Evaxion Biotech / PR](https://photos.watchmedier.dk/watchmedier/resize:fill:3840:0:0/plain/https://photos.watchmedier.dk/Images/article14182291.ece/ALTERNATES/schema-16_9/doc7lk6rega0tf112y8cc9c.jpg)
Biotech firm Evaxion Biotech has decided to take its EVX-03 candidate, a potential treatment for non-small cell lung cancer (NSCLC), into the clinical phase.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.